Association of urinary bisphenol A concentration with medical disorders and laboratory abnormalities in adults.

CONTEXT Bisphenol A (BPA) is widely used in epoxy resins lining food and beverage containers. Evidence of effects in animals has generated concern over low-level chronic exposures in humans. OBJECTIVE To examine associations between urinary BPA concentrations and adult health status. DESIGN, SETTING, AND PARTICIPANTS Cross-sectional analysis of BPA concentrations and health status in the general adult population of the United States, using data from the National Health and Nutrition Examination Survey 2003-2004. Participants were 1455 adults aged 18 through 74 years with measured urinary BPA and urine creatinine concentrations. Regression models were adjusted for age, sex, race/ethnicity, education, income, smoking, body mass index, waist circumference, and urinary creatinine concentration. The sample provided 80% power to detect unadjusted odds ratios (ORs) of 1.4 for diagnoses of 5% prevalence per 1-SD change in BPA concentration, or standardized regression coefficients of 0.075 for liver enzyme concentrations, at a significance level of P < .05. MAIN OUTCOME MEASURES Chronic disease diagnoses plus blood markers of liver function, glucose homeostasis, inflammation, and lipid changes. RESULTS Higher urinary BPA concentrations were associated with cardiovascular diagnoses in age-, sex-, and fully adjusted models (OR per 1-SD increase in BPA concentration, 1.39; 95% confidence interval [CI], 1.18-1.63; P = .001 with full adjustment). Higher BPA concentrations were also associated with diabetes (OR per 1-SD increase in BPA concentration, 1.39; 95% confidence interval [CI], 1.21-1.60; P < .001) but not with other studied common diseases. In addition, higher BPA concentrations were associated with clinically abnormal concentrations of the liver enzymes gamma-glutamyltransferase (OR per 1-SD increase in BPA concentration, 1.29; 95% CI, 1.14-1.46; P < .001) and alkaline phosphatase (OR per 1-SD increase in BPA concentration, 1.48; 95% CI, 1.18-1.85; P = .002). CONCLUSION Higher BPA exposure, reflected in higher urinary concentrations of BPA, may be associated with avoidable morbidity in the community-dwelling adult population.

[1]  Edward L. Korn,et al.  Analysis of Large Health Surveys: Accounting for the Sampling Design , 1995 .

[2]  L. Cameron,et al.  Polybrominated Biphenyls, Polychlorinated Biphenyls, Body Weight, and Incidence of Adult-Onset Diabetes Mellitus , 2006, Epidemiology.

[3]  Masatoshi Morita,et al.  Bisphenol A levels in human urine. , 2002, Environmental health perspectives.

[4]  C. Hughes,et al.  An Extensive New Literature Concerning Low-Dose Effects of Bisphenol A Shows the Need for a New Risk Assessment , 2005, Environmental health perspectives.

[5]  Julie E Goodman,et al.  An Updated Weight of the Evidence Evaluation of Reproductive and Developmental Effects of Low Doses of Bisphenol A , 2006, Critical reviews in toxicology.

[6]  Frederick S vom Saal,et al.  Large effects from small exposures. III. Endocrine mechanisms mediating effects of bisphenol A at levels of human exposure. , 2006, Endocrinology.

[7]  Samuel P. Caudill,et al.  Urinary Creatinine Concentrations in the U.S. Population: Implications for Urinary Biologic Monitoring Measurements , 2004, Environmental health perspectives.

[8]  P. Mathur,et al.  Bisphenol A induces reactive oxygen species generation in the liver of male rats. , 2003, Toxicology.

[9]  Antonia M. Calafat,et al.  Exposure of the U.S. Population to Bisphenol A and 4-tertiary-Octylphenol: 2003–2004 , 2007, Environmental health perspectives.

[10]  W D Plummer,et al.  Power and sample size calculations for studies involving linear regression. , 1998, Controlled clinical trials.

[11]  A. Calafat,et al.  Temporal Variability and Predictors of Urinary Bisphenol A Concentrations in Men and Women , 2007, Environmental health perspectives.

[12]  C. Ripoll,et al.  Bisphenol-A disruption of the endocrine pancreas and blood glucose homeostasis. , 2008, International journal of andrology.

[13]  Laura N. Vandenberg,et al.  Human exposure to bisphenol A (BPA). , 2007, Reproductive toxicology.

[14]  S. Ohta,et al.  Potent estrogenic metabolites of bisphenol A and bisphenol B formed by rat liver S9 fraction: their structures and estrogenic potency. , 2004, Toxicological sciences : an official journal of the Society of Toxicology.

[15]  V. Preedy,et al.  National Health and Nutrition Examination Survey , 2010 .

[16]  K. Nakao,et al.  Thyroid hormone action is disrupted by bisphenol A as an antagonist. , 2002, The Journal of clinical endocrinology and metabolism.

[17]  J. Ashby,et al.  Comparison of the modulatory effects of human and rat liver microsomal metabolism on the estrogenicity of bisphenol A: implications for extrapolation to humans. , 2001, The Journal of pharmacology and experimental therapeutics.

[18]  Shaw Watanabe,et al.  Measurement of bisphenol A in human urine using liquid chromatography with multi-channel coulometric electrochemical detection. , 2002, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[19]  F. Grün,et al.  Perturbed nuclear receptor signaling by environmental obesogens as emerging factors in the obesity crisis , 2007, Reviews in Endocrine and Metabolic Disorders.

[20]  Paloma Alonso-Magdalena,et al.  The Estrogenic Effect of Bisphenol A Disrupts Pancreatic β-Cell Function In Vivo and Induces Insulin Resistance , 2005, Environmental health perspectives.

[21]  Y. Shimohigashi,et al.  Direct Evidence Revealing Structural Elements Essential for the High Binding Ability of Bisphenol A to Human Estrogen-Related Receptor-γ , 2007, Environmental health perspectives.

[22]  Harvey J Clewell,et al.  Evaluation of oral and intravenous route pharmacokinetics, plasma protein binding, and uterine tissue dose metrics of bisphenol A: a physiologically based pharmacokinetic approach. , 2005, Toxicological sciences : an official journal of the Society of Toxicology.

[23]  Shuk-Mei Ho,et al.  Chapel Hill bisphenol A expert panel consensus statement: integration of mechanisms, effects in animals and potential to impact human health at current levels of exposure. , 2007, Reproductive toxicology.

[24]  Y. Taketani,et al.  Positive relationship between androgen and the endocrine disruptor, bisphenol A, in normal women and women with ovarian dysfunction. , 2004, Endocrine journal.

[25]  Samuel P. Caudill,et al.  Urinary Concentrations of Bisphenol A and 4-Nonylphenol in a Human Reference Population , 2004, Environmental health perspectives.

[26]  Y. Nakagawa,et al.  Metabolism and cytotoxicity of bisphenol A and other bisphenols in isolated rat hepatocytes , 2000, Archives of Toxicology.

[27]  A. Nakajima,et al.  Life style-related diseases of the digestive system: endocrine disruptors stimulate lipid accumulation in target cells related to metabolic syndrome. , 2007, Journal of pharmacological sciences.

[28]  Wolfgang Völkel,et al.  Metabolism and kinetics of bisphenol a in humans at low doses following oral administration. , 2002, Chemical research in toxicology.

[29]  Wolfgang Völkel,et al.  Human exposure to bisphenol A by biomonitoring: methods, results and assessment of environmental exposures. , 2008, Toxicology and applied pharmacology.

[30]  S Z Cagen,et al.  Three-generation reproductive toxicity study of dietary bisphenol A in CD Sprague-Dawley rats. , 2002, Toxicological sciences : an official journal of the Society of Toxicology.

[31]  J. Heindel,et al.  Effects of endocrine disruptors on obesity. , 2008, International journal of andrology.

[32]  D. Bloch,et al.  A simple method of sample size calculation for linear and logistic regression. , 1998, Statistics in medicine.

[33]  William D. Dupont,et al.  Power and sample size calculations. A review and computer program. , 1990, Controlled clinical trials.

[34]  A. Atkinson,et al.  Biochemical and molecular changes at the cellular level in response to exposure to environmental estrogen-like chemicals. , 1997, Journal of toxicology and environmental health.

[35]  H. Yokota,et al.  Developmental increases in rat hepatic microsomal UDP-glucuronosyltransferase activities toward xenoestrogens and decreases during pregnancy. , 2002, Environmental health perspectives.

[36]  D. Jacobs,et al.  A Strong Dose-Response Relation Between Serum Concentrations of Persistent Organic Pollutants and Diabetes , 2006, Diabetes Care.